Emeryville, California, United States Tethys BioScience appeared to be the Corporate Investor, which was created in 2002. The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Emeryville.
Among the various public portfolio startups of the fund, we may underline Theravectys Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - France. Among the most successful fund investment fields, there are Health Care, Biopharma.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the Tethys BioScience, startups are often financed by Richard HENNESSY, Philippe ODDO, John PIETERS. In the next rounds fund is usually obtained by Bpifrance.
The important activity for fund was in 2013. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.
The fund was created by David Hodgson, Dr .Urdea, Mickey S. Urdea.
| Fund Name | Location |
| 11-11 Ventures | Alpharetta, Georgia, United States |
| Bridges Alliance Partners | - |
| Brown Trust | - |
| Cielo Talent | Brookfield, United States, Wisconsin |
| Cineplex Entertainment | Canada, Ontario, Toronto |
| Crescat Capital | Colorado, Denver, United States |
| Dutch Founders Fund | Amsterdam, Noord-Holland, The Netherlands |
| GO Ventures | - |
| Gold Mountains Asset Management Co. Ltd | China, Hong Kong, Kowloon |
| KES 7 Capital | Canada, Ontario, Toronto |
| LifeArc | England, London, United Kingdom |
| Neoplux | Seoul, Seoul-t'ukpyolsi, South Korea |
| Qinhuangdao Aosheng Investment | China, Hebei, Qinhuangdao |
| ReBoost | Japan, Tokyo |
| Schwab Institutional | California, San Francisco, United States |
| Tres Monos Capital | - |
| UNIQUE INNOVATION FUND | - |
| Unlock Venture Partners | Seattle, United States, Washington |
| Zhongtai Investment | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 